Skip to main content
. Author manuscript; available in PMC: 2017 Jun 13.
Published in final edited form as: Mol Pharm. 2016 May 13;13(6):1866–1878. doi: 10.1021/acs.molpharmaceut.6b00036

Figure 1.

Figure 1

Plasma concentration (Cp) as a function of time after administration of G3NH2 and G3NH2-24PEG1000 via (a) pharyngeal aspiration (P.A.) and (b) intravenous injection (iv) (n = 3 per group). The statistical analysis was performed between G3NH2 and G3NH2-24PEG1000 with Student’s t test (**p < 0.01, and ***p < 0.001).